For example, IDH-wildtype astrocytic glioma carrying TERT promoter (TERTp) mutation, EGFR amplification, as well as gain-of-chromosome 7 and loss-of-chromosome 10 (+7/-10) are classified as GBM [4]. This evidence concerns the gene EGFR and glioblastoma.